Filing Flows › Microbot Medical (MBOT) › Q2 2026 › vs Q1 2026
Microbot Medical (MBOT) Q2 2026 vs Q1 2026 (quarter over quarter)
Microbot Medical's revenue rose $136K (+130%) from $105K in Q1 2026 to $241K in Q2 2026.
Microbot Medical, Q2 2026: revenue $241K, net loss $5.6M, operating cash flow −$5.0M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $241K | $105K | $136K | +130% |
| Other income, net | $561K | $649K | −$88K | -14% |
| Net loss | $5.6M | $3.7M | $2.0M | +53% |
| Costs & expenses | $6.4M | $4.4M | $2.0M | +45% |
| Operating costs | $6.4M | $4.4M | $2.0M | +45% |
| Research & development | $1.9M | $1.3M | $568K | +44% |
| SG&A | $3.7M | $3.0M | $655K | +22% |
| Operating cash sources | $5.6M | $3.7M | $2.0M | +53% |
| Depreciation & amortization | $15K | $12K | $3K | +25% |
| Share-based compensation | $433K | $222K | $211K | +95% |
| Working capital & other | $190K | −$1.6M | $1.8M | — |
| Cash used in operations | $5.0M | $5.1M | −$64K | -1% |
| Net loss absorbed | $5.6M | $3.7M | $2.0M | +53% |
Questions
How much did Microbot Medical's revenue grow quarter over quarter in Q2 2026?
Microbot Medical's revenue rose $136K (+130%) from $105K in Q1 2026 to $241K in Q2 2026.